Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Mark I. Rosenblatt, MD, PhD, MBA, is a distinguished academic leader, ophthalmologist, and researcher. He currently serves as the Dean of the University of Illinois College of Medicine, one of the largest and most diverse medical schools in the United States. Dr. Rosenblatt is an internationally recognized expert in corneal diseases, particularly focusing on corneal nerve regeneration, dry eye disease, and the development of novel therapies for ocular surface disorders. His leadership emphasizes innovation in medical education, pioneering research, and compassionate patient care. He holds an MD from the University of Miami Miller School of Medicine, a PhD in Biochemistry and Molecular Biology from the University of Miami, and an MBA from NYU Stern School of Business, reflecting his multifaceted expertise in medicine, science, and administration.
Mark Rosenblatt's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Appointed in 2017, he leads strategic initiatives to advance the college's mission in education, research, and clinical service across its Chicago, Peoria, Rockford, and Urbana campuses.
His laboratory has made significant contributions to understanding how corneal nerves regenerate and has developed innovative approaches to treat conditions related to corneal nerve damage and ocular surface disease. He holds multiple patents in this area.
Elected as a Fellow of the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), and the National Academy of Inventors (NAI), recognizing his significant contributions to ophthalmology, vision research, and innovation.
Has served on numerous national committees, NIH study sections, and editorial boards, shaping policy and research directions in ophthalmology and vision science.
His research has been continuously funded by the National Institutes of Health (NIH) and other prestigious foundations, underscoring the impact and quality of his scientific work.
Yale University - Yale School of Management - Year 1983
Yale University - Year 1977
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Rationalwave Capital Partners is an early-stage venture capital firm based in the San Francisco Bay Area, focusing on transformative B2B SaaS, AI/ML, Deep Tech, FinTech, and Healthcare IT companies. They invest from pre-seed to Series A stages, aiming to partner with visionary founders. Beyond capital, Rationalwave provides strategic guidance, operational support, and access to their extensive network to help portfolio companies scale and achieve market leadership. They emphasize a hands-on approach to support innovation and growth in their chosen sectors.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.